Sample Name	Protocol REF	Date	Performer	Parameter Value[chromatography instrument]	Parameter Value[chromatography column]	Parameter Value[elution program]	Extract Name	Protocol REF	Date	Performer	MS Assay Name	Parameter Value[randomized run order]	Parameter Value[injection mode]	Parameter Value[instrument]	Parameter Value[scan polarity]	Raw Spectral Data File
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#0_blood_extract-150	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-150_run-0	300	LC	Agilent QTOF	negative	acquired-data-150_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#0_blood_extract-150	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-150_run-1	301	LC	Agilent QTOF	negative	acquired-data-150_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#1_blood_extract-151	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-151_run-0	302	LC	Agilent QTOF	negative	acquired-data-151_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#1_blood_extract-151	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-151_run-1	303	LC	Agilent QTOF	negative	acquired-data-151_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#2_blood_extract-152	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-152_run-0	304	LC	Agilent QTOF	negative	acquired-data-152_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#2_blood_extract-152	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-152_run-1	305	LC	Agilent QTOF	negative	acquired-data-152_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#3_blood_extract-153	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-153_run-0	306	LC	Agilent QTOF	negative	acquired-data-153_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#3_blood_extract-153	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-153_run-1	307	LC	Agilent QTOF	negative	acquired-data-153_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#4_blood_extract-154	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-154_run-0	308	LC	Agilent QTOF	negative	acquired-data-154_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#0_sample#4_blood_extract-154	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-154_run-1	309	LC	Agilent QTOF	negative	acquired-data-154_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#0_blood_extract-155	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-155_run-1	311	LC	Agilent QTOF	negative	acquired-data-155_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#0_blood_extract-155	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-155_run-0	310	LC	Agilent QTOF	negative	acquired-data-155_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#1_blood_extract-156	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-156_run-0	312	LC	Agilent QTOF	negative	acquired-data-156_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#1_blood_extract-156	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-156_run-1	313	LC	Agilent QTOF	negative	acquired-data-156_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#2_blood_extract-157	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-157_run-1	315	LC	Agilent QTOF	negative	acquired-data-157_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#2_blood_extract-157	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-157_run-0	314	LC	Agilent QTOF	negative	acquired-data-157_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#3_blood_extract-158	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-158_run-1	317	LC	Agilent QTOF	negative	acquired-data-158_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#3_blood_extract-158	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-158_run-0	316	LC	Agilent QTOF	negative	acquired-data-158_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#4_blood_extract-159	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-159_run-1	319	LC	Agilent QTOF	negative	acquired-data-159_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#1_sample#4_blood_extract-159	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-159_run-0	318	LC	Agilent QTOF	negative	acquired-data-159_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#0_blood_extract-160	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-160_run-1	321	LC	Agilent QTOF	negative	acquired-data-160_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#0_blood_extract-160	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-160_run-0	320	LC	Agilent QTOF	negative	acquired-data-160_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#1_blood_extract-161	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-161_run-1	323	LC	Agilent QTOF	negative	acquired-data-161_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#1_blood_extract-161	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-161_run-0	322	LC	Agilent QTOF	negative	acquired-data-161_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#2_blood_extract-162	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-162_run-1	325	LC	Agilent QTOF	negative	acquired-data-162_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#2_blood_extract-162	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-162_run-0	324	LC	Agilent QTOF	negative	acquired-data-162_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#3_blood_extract-163	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-163_run-0	326	LC	Agilent QTOF	negative	acquired-data-163_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#3_blood_extract-163	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-163_run-1	327	LC	Agilent QTOF	negative	acquired-data-163_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#4_blood_extract-164	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-164_run-0	328	LC	Agilent QTOF	negative	acquired-data-164_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#2_sample#4_blood_extract-164	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-164_run-1	329	LC	Agilent QTOF	negative	acquired-data-164_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#0_blood_extract-165	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-165_run-1	331	LC	Agilent QTOF	negative	acquired-data-165_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#0_blood_extract-165	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-165_run-0	330	LC	Agilent QTOF	negative	acquired-data-165_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#1_blood_extract-166	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-166_run-1	333	LC	Agilent QTOF	negative	acquired-data-166_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#1_blood_extract-166	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-166_run-0	332	LC	Agilent QTOF	negative	acquired-data-166_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#2_blood_extract-167	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-167_run-1	335	LC	Agilent QTOF	negative	acquired-data-167_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#2_blood_extract-167	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-167_run-0	334	LC	Agilent QTOF	negative	acquired-data-167_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#3_blood_extract-168	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-168_run-0	336	LC	Agilent QTOF	negative	acquired-data-168_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#3_blood_extract-168	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-168_run-1	337	LC	Agilent QTOF	negative	acquired-data-168_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#4_blood_extract-169	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-169_run-0	338	LC	Agilent QTOF	negative	acquired-data-169_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#3_sample#4_blood_extract-169	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-169_run-1	339	LC	Agilent QTOF	negative	acquired-data-169_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#0_blood_extract-170	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-170_run-0	340	LC	Agilent QTOF	negative	acquired-data-170_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#0_blood_extract-170	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-170_run-1	341	LC	Agilent QTOF	negative	acquired-data-170_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#1_blood_extract-171	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-171_run-1	343	LC	Agilent QTOF	negative	acquired-data-171_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#1_blood_extract-171	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-171_run-0	342	LC	Agilent QTOF	negative	acquired-data-171_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#2_blood_extract-172	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-172_run-1	345	LC	Agilent QTOF	negative	acquired-data-172_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#2_blood_extract-172	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-172_run-0	344	LC	Agilent QTOF	negative	acquired-data-172_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#3_blood_extract-173	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-173_run-1	347	LC	Agilent QTOF	negative	acquired-data-173_platform-LC_negative_run-1.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#3_blood_extract-173	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-173_run-0	346	LC	Agilent QTOF	negative	acquired-data-173_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#4_blood_extract-174	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-174_run-0	348	LC	Agilent QTOF	negative	acquired-data-174_platform-LC_negative_run-0.mzml.gz
studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_0b05bafa-3a42-4a86-a6b1-2b9a0ddc55ac_subject#4_sample#4_blood_extract-174	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-174_run-1	349	LC	Agilent QTOF	negative	acquired-data-174_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#0_blood_extract-175	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-175_run-1	351	LC	Agilent QTOF	negative	acquired-data-175_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#0_blood_extract-175	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-175_run-0	350	LC	Agilent QTOF	negative	acquired-data-175_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#1_blood_extract-176	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-176_run-0	352	LC	Agilent QTOF	negative	acquired-data-176_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#1_blood_extract-176	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-176_run-1	353	LC	Agilent QTOF	negative	acquired-data-176_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#2_blood_extract-177	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-177_run-0	354	LC	Agilent QTOF	negative	acquired-data-177_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#2_blood_extract-177	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-177_run-1	355	LC	Agilent QTOF	negative	acquired-data-177_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#3_blood_extract-178	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-178_run-0	356	LC	Agilent QTOF	negative	acquired-data-178_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#3_blood_extract-178	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-178_run-1	357	LC	Agilent QTOF	negative	acquired-data-178_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#4_blood_extract-179	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-179_run-1	359	LC	Agilent QTOF	negative	acquired-data-179_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#0_sample#4_blood_extract-179	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-179_run-0	358	LC	Agilent QTOF	negative	acquired-data-179_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#0_blood_extract-180	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-180_run-0	360	LC	Agilent QTOF	negative	acquired-data-180_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#0_blood_extract-180	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-180_run-1	361	LC	Agilent QTOF	negative	acquired-data-180_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#1_blood_extract-181	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-181_run-1	363	LC	Agilent QTOF	negative	acquired-data-181_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#1_blood_extract-181	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-181_run-0	362	LC	Agilent QTOF	negative	acquired-data-181_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#2_blood_extract-182	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-182_run-0	364	LC	Agilent QTOF	negative	acquired-data-182_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#2_blood_extract-182	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-182_run-1	365	LC	Agilent QTOF	negative	acquired-data-182_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#3_blood_extract-183	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-183_run-1	367	LC	Agilent QTOF	negative	acquired-data-183_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#3_blood_extract-183	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-183_run-0	366	LC	Agilent QTOF	negative	acquired-data-183_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#4_blood_extract-184	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-184_run-0	368	LC	Agilent QTOF	negative	acquired-data-184_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#1_sample#4_blood_extract-184	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-184_run-1	369	LC	Agilent QTOF	negative	acquired-data-184_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#0_blood_extract-185	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-185_run-1	371	LC	Agilent QTOF	negative	acquired-data-185_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#0_blood_extract-185	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-185_run-0	370	LC	Agilent QTOF	negative	acquired-data-185_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#1_blood_extract-186	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-186_run-1	373	LC	Agilent QTOF	negative	acquired-data-186_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#1_blood_extract-186	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-186_run-0	372	LC	Agilent QTOF	negative	acquired-data-186_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#2_blood_extract-187	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-187_run-1	375	LC	Agilent QTOF	negative	acquired-data-187_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#2_blood_extract-187	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-187_run-0	374	LC	Agilent QTOF	negative	acquired-data-187_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#3_blood_extract-188	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-188_run-0	376	LC	Agilent QTOF	negative	acquired-data-188_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#3_blood_extract-188	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-188_run-1	377	LC	Agilent QTOF	negative	acquired-data-188_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#4_blood_extract-189	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-189_run-0	378	LC	Agilent QTOF	negative	acquired-data-189_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#2_sample#4_blood_extract-189	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-189_run-1	379	LC	Agilent QTOF	negative	acquired-data-189_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#0_blood_extract-190	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-190_run-1	381	LC	Agilent QTOF	negative	acquired-data-190_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#0_blood_extract-190	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-190_run-0	380	LC	Agilent QTOF	negative	acquired-data-190_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#1_blood_extract-191	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-191_run-1	383	LC	Agilent QTOF	negative	acquired-data-191_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#1_blood_extract-191	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-191_run-0	382	LC	Agilent QTOF	negative	acquired-data-191_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#2_blood_extract-192	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-192_run-0	384	LC	Agilent QTOF	negative	acquired-data-192_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#2_blood_extract-192	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-192_run-1	385	LC	Agilent QTOF	negative	acquired-data-192_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#3_blood_extract-193	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-193_run-1	387	LC	Agilent QTOF	negative	acquired-data-193_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#3_blood_extract-193	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-193_run-0	386	LC	Agilent QTOF	negative	acquired-data-193_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#4_blood_extract-194	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-194_run-1	389	LC	Agilent QTOF	negative	acquired-data-194_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#3_sample#4_blood_extract-194	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-194_run-0	388	LC	Agilent QTOF	negative	acquired-data-194_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#0_blood_extract-195	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-195_run-0	390	LC	Agilent QTOF	negative	acquired-data-195_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#0_blood_extract-195	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-195_run-1	391	LC	Agilent QTOF	negative	acquired-data-195_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#1_blood_extract-196	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-196_run-1	393	LC	Agilent QTOF	negative	acquired-data-196_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#1_blood_extract-196	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-196_run-0	392	LC	Agilent QTOF	negative	acquired-data-196_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#2_blood_extract-197	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-197_run-0	394	LC	Agilent QTOF	negative	acquired-data-197_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#2_blood_extract-197	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-197_run-1	395	LC	Agilent QTOF	negative	acquired-data-197_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#3_blood_extract-198	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-198_run-1	397	LC	Agilent QTOF	negative	acquired-data-198_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#3_blood_extract-198	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-198_run-0	396	LC	Agilent QTOF	negative	acquired-data-198_platform-LC_negative_run-0.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#4_blood_extract-199	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-199_run-1	399	LC	Agilent QTOF	negative	acquired-data-199_platform-LC_negative_run-1.mzml.gz
studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_23bf023d-1cd1-4963-be46-c6f099be4ea8_subject#4_sample#4_blood_extract-199	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-199_run-0	398	LC	Agilent QTOF	negative	acquired-data-199_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#0_blood_extract-50	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-50_run-0	100	LC	Agilent QTOF	negative	acquired-data-50_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#0_blood_extract-50	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-50_run-1	101	LC	Agilent QTOF	negative	acquired-data-50_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#1_blood_extract-51	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-51_run-1	103	LC	Agilent QTOF	negative	acquired-data-51_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#1_blood_extract-51	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-51_run-0	102	LC	Agilent QTOF	negative	acquired-data-51_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#2_blood_extract-52	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-52_run-0	104	LC	Agilent QTOF	negative	acquired-data-52_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#2_blood_extract-52	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-52_run-1	105	LC	Agilent QTOF	negative	acquired-data-52_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#3_blood_extract-53	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-53_run-1	107	LC	Agilent QTOF	negative	acquired-data-53_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#3_blood_extract-53	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-53_run-0	106	LC	Agilent QTOF	negative	acquired-data-53_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#4_blood_extract-54	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-54_run-1	109	LC	Agilent QTOF	negative	acquired-data-54_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#0_sample#4_blood_extract-54	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-54_run-0	108	LC	Agilent QTOF	negative	acquired-data-54_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#0_blood_extract-55	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-55_run-1	111	LC	Agilent QTOF	negative	acquired-data-55_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#0_blood_extract-55	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-55_run-0	110	LC	Agilent QTOF	negative	acquired-data-55_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#1_blood_extract-56	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-56_run-0	112	LC	Agilent QTOF	negative	acquired-data-56_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#1_blood_extract-56	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-56_run-1	113	LC	Agilent QTOF	negative	acquired-data-56_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#2_blood_extract-57	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-57_run-1	115	LC	Agilent QTOF	negative	acquired-data-57_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#2_blood_extract-57	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-57_run-0	114	LC	Agilent QTOF	negative	acquired-data-57_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#3_blood_extract-58	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-58_run-0	116	LC	Agilent QTOF	negative	acquired-data-58_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#3_blood_extract-58	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-58_run-1	117	LC	Agilent QTOF	negative	acquired-data-58_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#4_blood_extract-59	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-59_run-0	118	LC	Agilent QTOF	negative	acquired-data-59_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#1_sample#4_blood_extract-59	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-59_run-1	119	LC	Agilent QTOF	negative	acquired-data-59_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#0_blood_extract-60	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-60_run-0	120	LC	Agilent QTOF	negative	acquired-data-60_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#0_blood_extract-60	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-60_run-1	121	LC	Agilent QTOF	negative	acquired-data-60_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#1_blood_extract-61	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-61_run-1	123	LC	Agilent QTOF	negative	acquired-data-61_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#1_blood_extract-61	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-61_run-0	122	LC	Agilent QTOF	negative	acquired-data-61_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#2_blood_extract-62	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-62_run-1	125	LC	Agilent QTOF	negative	acquired-data-62_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#2_blood_extract-62	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-62_run-0	124	LC	Agilent QTOF	negative	acquired-data-62_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#3_blood_extract-63	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-63_run-0	126	LC	Agilent QTOF	negative	acquired-data-63_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#3_blood_extract-63	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-63_run-1	127	LC	Agilent QTOF	negative	acquired-data-63_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#4_blood_extract-64	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-64_run-1	129	LC	Agilent QTOF	negative	acquired-data-64_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#2_sample#4_blood_extract-64	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-64_run-0	128	LC	Agilent QTOF	negative	acquired-data-64_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#0_blood_extract-65	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-65_run-1	131	LC	Agilent QTOF	negative	acquired-data-65_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#0_blood_extract-65	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-65_run-0	130	LC	Agilent QTOF	negative	acquired-data-65_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#1_blood_extract-66	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-66_run-1	133	LC	Agilent QTOF	negative	acquired-data-66_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#1_blood_extract-66	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-66_run-0	132	LC	Agilent QTOF	negative	acquired-data-66_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#2_blood_extract-67	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-67_run-1	135	LC	Agilent QTOF	negative	acquired-data-67_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#2_blood_extract-67	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-67_run-0	134	LC	Agilent QTOF	negative	acquired-data-67_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#3_blood_extract-68	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-68_run-0	136	LC	Agilent QTOF	negative	acquired-data-68_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#3_blood_extract-68	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-68_run-1	137	LC	Agilent QTOF	negative	acquired-data-68_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#4_blood_extract-69	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-69_run-1	139	LC	Agilent QTOF	negative	acquired-data-69_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#3_sample#4_blood_extract-69	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-69_run-0	138	LC	Agilent QTOF	negative	acquired-data-69_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#0_blood_extract-70	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-70_run-0	140	LC	Agilent QTOF	negative	acquired-data-70_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#0_blood_extract-70	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-70_run-1	141	LC	Agilent QTOF	negative	acquired-data-70_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#1_blood_extract-71	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-71_run-0	142	LC	Agilent QTOF	negative	acquired-data-71_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#1_blood_extract-71	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-71_run-1	143	LC	Agilent QTOF	negative	acquired-data-71_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#2_blood_extract-72	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-72_run-0	144	LC	Agilent QTOF	negative	acquired-data-72_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#2_blood_extract-72	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-72_run-1	145	LC	Agilent QTOF	negative	acquired-data-72_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#3_blood_extract-73	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-73_run-1	147	LC	Agilent QTOF	negative	acquired-data-73_platform-LC_negative_run-1.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#3_blood_extract-73	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-73_run-0	146	LC	Agilent QTOF	negative	acquired-data-73_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#4_blood_extract-74	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-74_run-0	148	LC	Agilent QTOF	negative	acquired-data-74_platform-LC_negative_run-0.mzml.gz
studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_3363760b-c65b-47d9-8cbf-d2276f2b95f1_subject#4_sample#4_blood_extract-74	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-74_run-1	149	LC	Agilent QTOF	negative	acquired-data-74_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#0_blood_extract-100	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-100_run-0	200	LC	Agilent QTOF	negative	acquired-data-100_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#0_blood_extract-100	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-100_run-1	201	LC	Agilent QTOF	negative	acquired-data-100_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#1_blood_extract-101	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-101_run-0	202	LC	Agilent QTOF	negative	acquired-data-101_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#1_blood_extract-101	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-101_run-1	203	LC	Agilent QTOF	negative	acquired-data-101_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#2_blood_extract-102	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-102_run-0	204	LC	Agilent QTOF	negative	acquired-data-102_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#2_blood_extract-102	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-102_run-1	205	LC	Agilent QTOF	negative	acquired-data-102_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#3_blood_extract-103	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-103_run-1	207	LC	Agilent QTOF	negative	acquired-data-103_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#3_blood_extract-103	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-103_run-0	206	LC	Agilent QTOF	negative	acquired-data-103_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#4_blood_extract-104	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-104_run-0	208	LC	Agilent QTOF	negative	acquired-data-104_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#0_sample#4_blood_extract-104	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-104_run-1	209	LC	Agilent QTOF	negative	acquired-data-104_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#0_blood_extract-105	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-105_run-0	210	LC	Agilent QTOF	negative	acquired-data-105_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#0_blood_extract-105	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-105_run-1	211	LC	Agilent QTOF	negative	acquired-data-105_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#1_blood_extract-106	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-106_run-1	213	LC	Agilent QTOF	negative	acquired-data-106_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#1_blood_extract-106	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-106_run-0	212	LC	Agilent QTOF	negative	acquired-data-106_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#2_blood_extract-107	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-107_run-1	215	LC	Agilent QTOF	negative	acquired-data-107_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#2_blood_extract-107	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-107_run-0	214	LC	Agilent QTOF	negative	acquired-data-107_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#3_blood_extract-108	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-108_run-1	217	LC	Agilent QTOF	negative	acquired-data-108_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#3_blood_extract-108	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-108_run-0	216	LC	Agilent QTOF	negative	acquired-data-108_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#4_blood_extract-109	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-109_run-0	218	LC	Agilent QTOF	negative	acquired-data-109_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#1_sample#4_blood_extract-109	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-109_run-1	219	LC	Agilent QTOF	negative	acquired-data-109_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#0_blood_extract-110	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-110_run-0	220	LC	Agilent QTOF	negative	acquired-data-110_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#0_blood_extract-110	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-110_run-1	221	LC	Agilent QTOF	negative	acquired-data-110_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#1_blood_extract-111	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-111_run-0	222	LC	Agilent QTOF	negative	acquired-data-111_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#1_blood_extract-111	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-111_run-1	223	LC	Agilent QTOF	negative	acquired-data-111_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#2_blood_extract-112	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-112_run-1	225	LC	Agilent QTOF	negative	acquired-data-112_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#2_blood_extract-112	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-112_run-0	224	LC	Agilent QTOF	negative	acquired-data-112_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#3_blood_extract-113	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-113_run-0	226	LC	Agilent QTOF	negative	acquired-data-113_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#3_blood_extract-113	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-113_run-1	227	LC	Agilent QTOF	negative	acquired-data-113_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#4_blood_extract-114	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-114_run-0	228	LC	Agilent QTOF	negative	acquired-data-114_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#2_sample#4_blood_extract-114	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-114_run-1	229	LC	Agilent QTOF	negative	acquired-data-114_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#0_blood_extract-115	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-115_run-0	230	LC	Agilent QTOF	negative	acquired-data-115_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#0_blood_extract-115	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-115_run-1	231	LC	Agilent QTOF	negative	acquired-data-115_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#1_blood_extract-116	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-116_run-1	233	LC	Agilent QTOF	negative	acquired-data-116_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#1_blood_extract-116	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-116_run-0	232	LC	Agilent QTOF	negative	acquired-data-116_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#2_blood_extract-117	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-117_run-1	235	LC	Agilent QTOF	negative	acquired-data-117_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#2_blood_extract-117	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-117_run-0	234	LC	Agilent QTOF	negative	acquired-data-117_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#3_blood_extract-118	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-118_run-0	236	LC	Agilent QTOF	negative	acquired-data-118_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#3_blood_extract-118	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-118_run-1	237	LC	Agilent QTOF	negative	acquired-data-118_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#4_blood_extract-119	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-119_run-0	238	LC	Agilent QTOF	negative	acquired-data-119_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#3_sample#4_blood_extract-119	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-119_run-1	239	LC	Agilent QTOF	negative	acquired-data-119_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#0_blood_extract-120	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-120_run-0	240	LC	Agilent QTOF	negative	acquired-data-120_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#0_blood_extract-120	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-120_run-1	241	LC	Agilent QTOF	negative	acquired-data-120_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#1_blood_extract-121	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-121_run-0	242	LC	Agilent QTOF	negative	acquired-data-121_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#1_blood_extract-121	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-121_run-1	243	LC	Agilent QTOF	negative	acquired-data-121_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#2_blood_extract-122	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-122_run-1	245	LC	Agilent QTOF	negative	acquired-data-122_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#2_blood_extract-122	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-122_run-0	244	LC	Agilent QTOF	negative	acquired-data-122_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#3_blood_extract-123	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-123_run-0	246	LC	Agilent QTOF	negative	acquired-data-123_platform-LC_negative_run-0.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#3_blood_extract-123	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-123_run-1	247	LC	Agilent QTOF	negative	acquired-data-123_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#4_blood_extract-124	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-124_run-1	249	LC	Agilent QTOF	negative	acquired-data-124_platform-LC_negative_run-1.mzml.gz
studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_5701c5c1-dbb0-4ff9-b032-3c142e891e72_subject#4_sample#4_blood_extract-124	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-124_run-0	248	LC	Agilent QTOF	negative	acquired-data-124_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#0_blood_extract-0	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-0_run-1	1	LC	Agilent QTOF	negative	acquired-data-0_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#0_blood_extract-0	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-0_run-0	0	LC	Agilent QTOF	negative	acquired-data-0_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#1_blood_extract-1	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-1_run-0	2	LC	Agilent QTOF	negative	acquired-data-1_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#1_blood_extract-1	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-1_run-1	3	LC	Agilent QTOF	negative	acquired-data-1_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#2_blood_extract-2	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-2_run-0	4	LC	Agilent QTOF	negative	acquired-data-2_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#2_blood_extract-2	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-2_run-1	5	LC	Agilent QTOF	negative	acquired-data-2_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#3_blood_extract-3	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-3_run-0	6	LC	Agilent QTOF	negative	acquired-data-3_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#3_blood_extract-3	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-3_run-1	7	LC	Agilent QTOF	negative	acquired-data-3_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#4_blood_extract-4	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-4_run-1	9	LC	Agilent QTOF	negative	acquired-data-4_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#0_sample#4_blood_extract-4	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-4_run-0	8	LC	Agilent QTOF	negative	acquired-data-4_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#0_blood_extract-5	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-5_run-1	11	LC	Agilent QTOF	negative	acquired-data-5_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#0_blood_extract-5	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-5_run-0	10	LC	Agilent QTOF	negative	acquired-data-5_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#1_blood_extract-6	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-6_run-0	12	LC	Agilent QTOF	negative	acquired-data-6_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#1_blood_extract-6	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-6_run-1	13	LC	Agilent QTOF	negative	acquired-data-6_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#2_blood_extract-7	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-7_run-0	14	LC	Agilent QTOF	negative	acquired-data-7_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#2_blood_extract-7	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-7_run-1	15	LC	Agilent QTOF	negative	acquired-data-7_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#3_blood_extract-8	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-8_run-0	16	LC	Agilent QTOF	negative	acquired-data-8_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#3_blood_extract-8	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-8_run-1	17	LC	Agilent QTOF	negative	acquired-data-8_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#4_blood_extract-9	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-9_run-0	18	LC	Agilent QTOF	negative	acquired-data-9_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#1_sample#4_blood_extract-9	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-9_run-1	19	LC	Agilent QTOF	negative	acquired-data-9_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#0_blood_extract-10	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-10_run-0	20	LC	Agilent QTOF	negative	acquired-data-10_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#0_blood_extract-10	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-10_run-1	21	LC	Agilent QTOF	negative	acquired-data-10_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#1_blood_extract-11	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-11_run-0	22	LC	Agilent QTOF	negative	acquired-data-11_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#1_blood_extract-11	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-11_run-1	23	LC	Agilent QTOF	negative	acquired-data-11_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#2_blood_extract-12	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-12_run-0	24	LC	Agilent QTOF	negative	acquired-data-12_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#2_blood_extract-12	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-12_run-1	25	LC	Agilent QTOF	negative	acquired-data-12_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#3_blood_extract-13	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-13_run-1	27	LC	Agilent QTOF	negative	acquired-data-13_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#3_blood_extract-13	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-13_run-0	26	LC	Agilent QTOF	negative	acquired-data-13_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#4_blood_extract-14	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-14_run-1	29	LC	Agilent QTOF	negative	acquired-data-14_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#2_sample#4_blood_extract-14	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-14_run-0	28	LC	Agilent QTOF	negative	acquired-data-14_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#0_blood_extract-15	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-15_run-1	31	LC	Agilent QTOF	negative	acquired-data-15_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#0_blood_extract-15	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-15_run-0	30	LC	Agilent QTOF	negative	acquired-data-15_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#1_blood_extract-16	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-16_run-0	32	LC	Agilent QTOF	negative	acquired-data-16_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#1_blood_extract-16	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-16_run-1	33	LC	Agilent QTOF	negative	acquired-data-16_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#2_blood_extract-17	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-17_run-1	35	LC	Agilent QTOF	negative	acquired-data-17_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#2_blood_extract-17	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-17_run-0	34	LC	Agilent QTOF	negative	acquired-data-17_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#3_blood_extract-18	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-18_run-1	37	LC	Agilent QTOF	negative	acquired-data-18_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#3_blood_extract-18	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-18_run-0	36	LC	Agilent QTOF	negative	acquired-data-18_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#4_blood_extract-19	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-19_run-1	39	LC	Agilent QTOF	negative	acquired-data-19_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#3_sample#4_blood_extract-19	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-19_run-0	38	LC	Agilent QTOF	negative	acquired-data-19_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#0_blood_extract-20	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-20_run-1	41	LC	Agilent QTOF	negative	acquired-data-20_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#0_blood_extract-20	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-20_run-0	40	LC	Agilent QTOF	negative	acquired-data-20_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#1_blood_extract-21	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-21_run-1	43	LC	Agilent QTOF	negative	acquired-data-21_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#1_blood_extract-21	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-21_run-0	42	LC	Agilent QTOF	negative	acquired-data-21_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#2_blood_extract-22	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-22_run-0	44	LC	Agilent QTOF	negative	acquired-data-22_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#2_blood_extract-22	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-22_run-1	45	LC	Agilent QTOF	negative	acquired-data-22_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#3_blood_extract-23	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-23_run-1	47	LC	Agilent QTOF	negative	acquired-data-23_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#3_blood_extract-23	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-23_run-0	46	LC	Agilent QTOF	negative	acquired-data-23_platform-LC_negative_run-0.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#4_blood_extract-24	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-24_run-1	49	LC	Agilent QTOF	negative	acquired-data-24_platform-LC_negative_run-1.mzml.gz
studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_6115b67e-c525-463c-8519-4139b169c675_subject#4_sample#4_blood_extract-24	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-24_run-0	48	LC	Agilent QTOF	negative	acquired-data-24_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#0_blood_extract-125	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-125_run-0	250	LC	Agilent QTOF	negative	acquired-data-125_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#0_blood_extract-125	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-125_run-1	251	LC	Agilent QTOF	negative	acquired-data-125_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#1_blood_extract-126	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-126_run-1	253	LC	Agilent QTOF	negative	acquired-data-126_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#1_blood_extract-126	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-126_run-0	252	LC	Agilent QTOF	negative	acquired-data-126_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#2_blood_extract-127	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-127_run-0	254	LC	Agilent QTOF	negative	acquired-data-127_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#2_blood_extract-127	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-127_run-1	255	LC	Agilent QTOF	negative	acquired-data-127_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#3_blood_extract-128	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-128_run-1	257	LC	Agilent QTOF	negative	acquired-data-128_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#3_blood_extract-128	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-128_run-0	256	LC	Agilent QTOF	negative	acquired-data-128_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#4_blood_extract-129	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-129_run-0	258	LC	Agilent QTOF	negative	acquired-data-129_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#0_sample#4_blood_extract-129	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-129_run-1	259	LC	Agilent QTOF	negative	acquired-data-129_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#0_blood_extract-130	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-130_run-1	261	LC	Agilent QTOF	negative	acquired-data-130_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#0_blood_extract-130	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-130_run-0	260	LC	Agilent QTOF	negative	acquired-data-130_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#1_blood_extract-131	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-131_run-1	263	LC	Agilent QTOF	negative	acquired-data-131_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#1_blood_extract-131	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-131_run-0	262	LC	Agilent QTOF	negative	acquired-data-131_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#2_blood_extract-132	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-132_run-0	264	LC	Agilent QTOF	negative	acquired-data-132_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#2_blood_extract-132	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-132_run-1	265	LC	Agilent QTOF	negative	acquired-data-132_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#3_blood_extract-133	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-133_run-0	266	LC	Agilent QTOF	negative	acquired-data-133_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#3_blood_extract-133	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-133_run-1	267	LC	Agilent QTOF	negative	acquired-data-133_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#4_blood_extract-134	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-134_run-1	269	LC	Agilent QTOF	negative	acquired-data-134_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#1_sample#4_blood_extract-134	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-134_run-0	268	LC	Agilent QTOF	negative	acquired-data-134_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#0_blood_extract-135	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-135_run-1	271	LC	Agilent QTOF	negative	acquired-data-135_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#0_blood_extract-135	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-135_run-0	270	LC	Agilent QTOF	negative	acquired-data-135_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#1_blood_extract-136	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-136_run-0	272	LC	Agilent QTOF	negative	acquired-data-136_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#1_blood_extract-136	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-136_run-1	273	LC	Agilent QTOF	negative	acquired-data-136_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#2_blood_extract-137	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-137_run-1	275	LC	Agilent QTOF	negative	acquired-data-137_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#2_blood_extract-137	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-137_run-0	274	LC	Agilent QTOF	negative	acquired-data-137_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#3_blood_extract-138	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-138_run-1	277	LC	Agilent QTOF	negative	acquired-data-138_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#3_blood_extract-138	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-138_run-0	276	LC	Agilent QTOF	negative	acquired-data-138_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#4_blood_extract-139	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-139_run-1	279	LC	Agilent QTOF	negative	acquired-data-139_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#2_sample#4_blood_extract-139	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-139_run-0	278	LC	Agilent QTOF	negative	acquired-data-139_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#0_blood_extract-140	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-140_run-1	281	LC	Agilent QTOF	negative	acquired-data-140_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#0_blood_extract-140	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-140_run-0	280	LC	Agilent QTOF	negative	acquired-data-140_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#1_blood_extract-141	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-141_run-0	282	LC	Agilent QTOF	negative	acquired-data-141_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#1_blood_extract-141	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-141_run-1	283	LC	Agilent QTOF	negative	acquired-data-141_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#2_blood_extract-142	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-142_run-1	285	LC	Agilent QTOF	negative	acquired-data-142_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#2_blood_extract-142	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-142_run-0	284	LC	Agilent QTOF	negative	acquired-data-142_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#3_blood_extract-143	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-143_run-1	287	LC	Agilent QTOF	negative	acquired-data-143_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#3_blood_extract-143	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-143_run-0	286	LC	Agilent QTOF	negative	acquired-data-143_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#4_blood_extract-144	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-144_run-0	288	LC	Agilent QTOF	negative	acquired-data-144_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#3_sample#4_blood_extract-144	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-144_run-1	289	LC	Agilent QTOF	negative	acquired-data-144_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#0_blood_extract-145	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-145_run-1	291	LC	Agilent QTOF	negative	acquired-data-145_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#0_blood_extract-145	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-145_run-0	290	LC	Agilent QTOF	negative	acquired-data-145_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#1_blood_extract-146	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-146_run-1	293	LC	Agilent QTOF	negative	acquired-data-146_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#1_blood_extract-146	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-146_run-0	292	LC	Agilent QTOF	negative	acquired-data-146_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#2_blood_extract-147	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-147_run-1	295	LC	Agilent QTOF	negative	acquired-data-147_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#2_blood_extract-147	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-147_run-0	294	LC	Agilent QTOF	negative	acquired-data-147_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#3_blood_extract-148	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-148_run-1	297	LC	Agilent QTOF	negative	acquired-data-148_platform-LC_negative_run-1.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#3_blood_extract-148	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-148_run-0	296	LC	Agilent QTOF	negative	acquired-data-148_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#4_blood_extract-149	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-149_run-0	298	LC	Agilent QTOF	negative	acquired-data-149_platform-LC_negative_run-0.mzml.gz
studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_673a0129-cfd2-415f-ae6a-b87fe577613d_subject#4_sample#4_blood_extract-149	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-149_run-1	299	LC	Agilent QTOF	negative	acquired-data-149_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#0_blood_extract-25	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-25_run-0	50	LC	Agilent QTOF	negative	acquired-data-25_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#0_blood_extract-25	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-25_run-1	51	LC	Agilent QTOF	negative	acquired-data-25_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#1_blood_extract-26	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-26_run-1	53	LC	Agilent QTOF	negative	acquired-data-26_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#1_blood_extract-26	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-26_run-0	52	LC	Agilent QTOF	negative	acquired-data-26_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#2_blood_extract-27	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-27_run-1	55	LC	Agilent QTOF	negative	acquired-data-27_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#2_blood_extract-27	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-27_run-0	54	LC	Agilent QTOF	negative	acquired-data-27_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#3_blood_extract-28	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-28_run-0	56	LC	Agilent QTOF	negative	acquired-data-28_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#3_blood_extract-28	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-28_run-1	57	LC	Agilent QTOF	negative	acquired-data-28_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#4_blood_extract-29	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-29_run-1	59	LC	Agilent QTOF	negative	acquired-data-29_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#0_sample#4_blood_extract-29	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-29_run-0	58	LC	Agilent QTOF	negative	acquired-data-29_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#0_blood_extract-30	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-30_run-0	60	LC	Agilent QTOF	negative	acquired-data-30_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#0_blood_extract-30	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-30_run-1	61	LC	Agilent QTOF	negative	acquired-data-30_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#1_blood_extract-31	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-31_run-0	62	LC	Agilent QTOF	negative	acquired-data-31_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#1_blood_extract-31	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-31_run-1	63	LC	Agilent QTOF	negative	acquired-data-31_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#2_blood_extract-32	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-32_run-0	64	LC	Agilent QTOF	negative	acquired-data-32_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#2_blood_extract-32	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-32_run-1	65	LC	Agilent QTOF	negative	acquired-data-32_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#3_blood_extract-33	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-33_run-0	66	LC	Agilent QTOF	negative	acquired-data-33_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#3_blood_extract-33	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-33_run-1	67	LC	Agilent QTOF	negative	acquired-data-33_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#4_blood_extract-34	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-34_run-0	68	LC	Agilent QTOF	negative	acquired-data-34_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#1_sample#4_blood_extract-34	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-34_run-1	69	LC	Agilent QTOF	negative	acquired-data-34_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#0_blood_extract-35	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-35_run-0	70	LC	Agilent QTOF	negative	acquired-data-35_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#0_blood_extract-35	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-35_run-1	71	LC	Agilent QTOF	negative	acquired-data-35_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#1_blood_extract-36	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-36_run-1	73	LC	Agilent QTOF	negative	acquired-data-36_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#1_blood_extract-36	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-36_run-0	72	LC	Agilent QTOF	negative	acquired-data-36_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#2_blood_extract-37	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-37_run-1	75	LC	Agilent QTOF	negative	acquired-data-37_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#2_blood_extract-37	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-37_run-0	74	LC	Agilent QTOF	negative	acquired-data-37_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#3_blood_extract-38	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-38_run-1	77	LC	Agilent QTOF	negative	acquired-data-38_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#3_blood_extract-38	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-38_run-0	76	LC	Agilent QTOF	negative	acquired-data-38_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#4_blood_extract-39	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-39_run-0	78	LC	Agilent QTOF	negative	acquired-data-39_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#2_sample#4_blood_extract-39	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-39_run-1	79	LC	Agilent QTOF	negative	acquired-data-39_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#0_blood_extract-40	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-40_run-0	80	LC	Agilent QTOF	negative	acquired-data-40_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#0_blood_extract-40	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-40_run-1	81	LC	Agilent QTOF	negative	acquired-data-40_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#1_blood_extract-41	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-41_run-1	83	LC	Agilent QTOF	negative	acquired-data-41_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#1_blood_extract-41	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-41_run-0	82	LC	Agilent QTOF	negative	acquired-data-41_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#2_blood_extract-42	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-42_run-0	84	LC	Agilent QTOF	negative	acquired-data-42_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#2_blood_extract-42	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-42_run-1	85	LC	Agilent QTOF	negative	acquired-data-42_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#3_blood_extract-43	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-43_run-1	87	LC	Agilent QTOF	negative	acquired-data-43_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#3_blood_extract-43	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-43_run-0	86	LC	Agilent QTOF	negative	acquired-data-43_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#4_blood_extract-44	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-44_run-1	89	LC	Agilent QTOF	negative	acquired-data-44_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#3_sample#4_blood_extract-44	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-44_run-0	88	LC	Agilent QTOF	negative	acquired-data-44_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#0_blood_extract-45	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-45_run-1	91	LC	Agilent QTOF	negative	acquired-data-45_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#0_blood_extract-45	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-45_run-0	90	LC	Agilent QTOF	negative	acquired-data-45_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#1_blood_extract-46	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-46_run-0	92	LC	Agilent QTOF	negative	acquired-data-46_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#1_blood_extract-46	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-46_run-1	93	LC	Agilent QTOF	negative	acquired-data-46_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#2_blood_extract-47	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-47_run-0	94	LC	Agilent QTOF	negative	acquired-data-47_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#2_blood_extract-47	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-47_run-1	95	LC	Agilent QTOF	negative	acquired-data-47_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#3_blood_extract-48	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-48_run-1	97	LC	Agilent QTOF	negative	acquired-data-48_platform-LC_negative_run-1.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#3_blood_extract-48	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-48_run-0	96	LC	Agilent QTOF	negative	acquired-data-48_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#4_blood_extract-49	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-49_run-0	98	LC	Agilent QTOF	negative	acquired-data-49_platform-LC_negative_run-0.mzml.gz
studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_a953605b-4928-4a16-8fa2-b7db28fc67d1_subject#4_sample#4_blood_extract-49	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-49_run-1	99	LC	Agilent QTOF	negative	acquired-data-49_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#0_blood_extract-75	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-75_run-1	151	LC	Agilent QTOF	negative	acquired-data-75_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#0_blood_extract-75	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-75_run-0	150	LC	Agilent QTOF	negative	acquired-data-75_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#1_blood_extract-76	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-76_run-1	153	LC	Agilent QTOF	negative	acquired-data-76_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#1_blood_extract-76	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-76_run-0	152	LC	Agilent QTOF	negative	acquired-data-76_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#2_blood_extract-77	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-77_run-1	155	LC	Agilent QTOF	negative	acquired-data-77_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#2_blood_extract-77	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-77_run-0	154	LC	Agilent QTOF	negative	acquired-data-77_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#3_blood_extract-78	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-78_run-1	157	LC	Agilent QTOF	negative	acquired-data-78_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#3_blood_extract-78	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-78_run-0	156	LC	Agilent QTOF	negative	acquired-data-78_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#4_blood_extract-79	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-79_run-1	159	LC	Agilent QTOF	negative	acquired-data-79_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#0_sample#4_blood_extract-79	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-79_run-0	158	LC	Agilent QTOF	negative	acquired-data-79_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#0_blood_extract-80	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-80_run-1	161	LC	Agilent QTOF	negative	acquired-data-80_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#0_blood_extract-80	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-80_run-0	160	LC	Agilent QTOF	negative	acquired-data-80_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#1_blood_extract-81	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-81_run-1	163	LC	Agilent QTOF	negative	acquired-data-81_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#1_blood_extract-81	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-81_run-0	162	LC	Agilent QTOF	negative	acquired-data-81_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#2_blood_extract-82	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-82_run-1	165	LC	Agilent QTOF	negative	acquired-data-82_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#2_blood_extract-82	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-82_run-0	164	LC	Agilent QTOF	negative	acquired-data-82_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#3_blood_extract-83	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-83_run-1	167	LC	Agilent QTOF	negative	acquired-data-83_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#3_blood_extract-83	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-83_run-0	166	LC	Agilent QTOF	negative	acquired-data-83_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#4_blood_extract-84	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-84_run-1	169	LC	Agilent QTOF	negative	acquired-data-84_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#1_sample#4_blood_extract-84	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-84_run-0	168	LC	Agilent QTOF	negative	acquired-data-84_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#0_blood_extract-85	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-85_run-1	171	LC	Agilent QTOF	negative	acquired-data-85_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#0_blood_extract-85	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-85_run-0	170	LC	Agilent QTOF	negative	acquired-data-85_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#1_blood_extract-86	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-86_run-0	172	LC	Agilent QTOF	negative	acquired-data-86_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#1_blood_extract-86	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-86_run-1	173	LC	Agilent QTOF	negative	acquired-data-86_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#2_blood_extract-87	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-87_run-1	175	LC	Agilent QTOF	negative	acquired-data-87_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#2_blood_extract-87	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-87_run-0	174	LC	Agilent QTOF	negative	acquired-data-87_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#3_blood_extract-88	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-88_run-0	176	LC	Agilent QTOF	negative	acquired-data-88_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#3_blood_extract-88	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-88_run-1	177	LC	Agilent QTOF	negative	acquired-data-88_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#4_blood_extract-89	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-89_run-0	178	LC	Agilent QTOF	negative	acquired-data-89_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#2_sample#4_blood_extract-89	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-89_run-1	179	LC	Agilent QTOF	negative	acquired-data-89_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#0_blood_extract-90	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-90_run-1	181	LC	Agilent QTOF	negative	acquired-data-90_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#0_blood_extract-90	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-90_run-0	180	LC	Agilent QTOF	negative	acquired-data-90_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#1_blood_extract-91	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-91_run-0	182	LC	Agilent QTOF	negative	acquired-data-91_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#1_blood_extract-91	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-91_run-1	183	LC	Agilent QTOF	negative	acquired-data-91_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#2_blood_extract-92	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-92_run-1	185	LC	Agilent QTOF	negative	acquired-data-92_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#2_blood_extract-92	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-92_run-0	184	LC	Agilent QTOF	negative	acquired-data-92_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#3_blood_extract-93	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-93_run-1	187	LC	Agilent QTOF	negative	acquired-data-93_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#3_blood_extract-93	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-93_run-0	186	LC	Agilent QTOF	negative	acquired-data-93_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#4_blood_extract-94	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-94_run-1	189	LC	Agilent QTOF	negative	acquired-data-94_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#3_sample#4_blood_extract-94	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-94_run-0	188	LC	Agilent QTOF	negative	acquired-data-94_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#0_blood_extract-95	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-95_run-0	190	LC	Agilent QTOF	negative	acquired-data-95_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#0_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#0_blood_extract-95	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-95_run-1	191	LC	Agilent QTOF	negative	acquired-data-95_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#1_blood_extract-96	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-96_run-1	193	LC	Agilent QTOF	negative	acquired-data-96_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#1_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#1_blood_extract-96	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-96_run-0	192	LC	Agilent QTOF	negative	acquired-data-96_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#2_blood_extract-97	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-97_run-1	195	LC	Agilent QTOF	negative	acquired-data-97_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#2_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#2_blood_extract-97	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-97_run-0	194	LC	Agilent QTOF	negative	acquired-data-97_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#3_blood_extract-98	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-98_run-0	196	LC	Agilent QTOF	negative	acquired-data-98_platform-LC_negative_run-0.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#3_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#3_blood_extract-98	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-98_run-1	197	LC	Agilent QTOF	negative	acquired-data-98_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#4_blood_extract-99	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-99_run-1	199	LC	Agilent QTOF	negative	acquired-data-99_platform-LC_negative_run-1.mzml.gz
studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#4_blood	metabolite extraction	2018-01-05	Dan	Agilent Q12324A	AB Hydroxyapatite	Acetonitrile 90%, water 10% for 30 min, flow rate: 1ml/min	studygroup_e6494637-a880-4c58-aefd-3fc67e880ad9_subject#4_sample#4_blood_extract-99	LC-negative mass spectrometry	2018-01-05	Erin	assay-name-99_run-0	198	LC	Agilent QTOF	negative	acquired-data-99_platform-LC_negative_run-0.mzml.gz
